Effects of SGLT2 Inhibition via Empagliflozin on Cognitive and Physical Impairment in Frail Diabetic Elders with Chronic Kidney Disease.

Mone, Pasquale, Germano Guerra, Angela Lombardi, Maddalena Illario, Antonella Pansini, Anna Marro, Salvatore Frullone, et al. “Effects of SGLT2 Inhibition via Empagliflozin on Cognitive and Physical Impairment in Frail Diabetic Elders With Chronic Kidney Disease.”. Pharmacological Research, 2024, 107055.